Drugs panel to review applications for Covovax’s use among kids aged 2-11 yrs

New Delhi: The subject expert committee on COVID-19 of India’s drug regulator will on Friday review the applications of Serum Institute of India seeking emergency use authorization to use Covovax among those aged 2-7 years and 7-11 years, official sources said.

The two applications were submitted by Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute of India (SII), on March 16 and June 1.

Leave a Reply

Your email address will not be published.